Searle & Co. Sanofi Transaction History

Searle & Co.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Jul 19, 2018	SELL	$37.63 - $41.22 $978,380 - $1.07 Million	-26,000 Closed	0 $0
Q1 2018 Apr 25, 2018	SELL	$38.98 - $45.76 $70,164 - $82,368	-1,800 Reduced 6.47%	26,000 $1.04 Million
Q4 2017 Jan 17, 2018	SELL	$42.86 - $50.61 $30,002 - $35,427	-700 Reduced 2.46%	27,800 $1.2 Million
Q3 2017 Oct 27, 2017	BUY	$47.04 - $50.34 $1.34 Million - $1.43 Million	28,500	28,500 $1.42 Million

822

268M

1.9M

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $122B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

Get notified when there are updates to the investment portfolio of Searle & Co., based on Form 13F filings with the SEC.

Stay updated on Searle & Co. with notifications on news.